Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Dermal papilla cells are key for hair growth and color, influencing hair type and size, and their interaction with stem cells could help treat hair loss and color disorders.

The new facial treatment improved wrinkles and skin thickness, with most patients seeing results within a month, despite some temporary swelling and bruising.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

Clascoterone is safe for the heart, even at high doses.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

Epidermal stem cells show promise for future dermatology treatments due to ongoing advancements.

Exosomes show promise for future tissue regeneration.

Pantethine may boost the immune system's ability to fight sarcoma.

Tiny particles from 3D-grown skin cells speed up wound healing by promoting blood vessel growth.

CD4+ skin cells may be precursors to basal cell carcinoma.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

PRP might help with hair growth and skin rejuvenation, but more research is needed to prove its effectiveness.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

The document concludes that a complete skin restoration biomaterial does not yet exist, and more clinical trials are needed to ensure these therapies are safe and effective.

The conclusion is that closing scalp wounds is possible, but restoring hair without donor material is still a major challenge.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Different types of skin stem cells can change and adapt, which is important for developing new treatments.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

3D bioprinting with special hydrogels can create artificial skin that heals wounds and regrows hair in mice.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.